Key Market Segments:
By Product & Services
-
Consumables
-
Instruments
-
Services
By Workflow
-
Pre-sequencing
-
Sequencing
-
Data Analysis
By Technology
-
Sanger Sequencing
-
Next-Generation Sequencing
-
Whole Genome Sequencing (WGS)
-
Whole Exome Sequencing (WES)
-
Targeted Sequencing & Resequencing
-
-
Third Generation DNA Sequencing
-
Single-Molecule Real-Time Sequencing (SMRT)
-
Nanopore Sequencing
-
By Application
-
Oncology
-
Reproductive Health
-
Clinical Investigation
-
Agrigenomics & Forensics
-
HLA Typing/Immune System Monitoring
-
Metagenomics, Epidemiology & Drug Development
-
Consumer Genomics
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Leading companies include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, and BGI Group, all of which provide advanced DNA sequencing technologies for research and clinical applications.
Major trends include the rise of personalized medicine, advancements in cancer genomics, increasing use of sequencing in diagnostics, and the development of faster and more affordable sequencing technologies.
Industries such as healthcare, biotechnology, pharmaceuticals, agriculture, and forensic science benefit from DNA sequencing for applications like genetic testing, drug development, disease research, and crop improvement.
The projected market size for the DNA Sequencing Market is USD 52.1 billion by 2032.
The North American region dominated the DNA Sequencing Market in 2024, with a 42% share.